As of 2026-04-03, the Intrinsic Value of Korea Bio-Gen Co Ltd (318000.KQ) is 6,362.06 KRW. This 318000.KQ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 4,240.00 KRW, the upside of Korea Bio-Gen Co Ltd is 50.00%.
The range of the Intrinsic Value is 5,264.63 - 8,151.69 KRW
Based on its market price of 4,240.00 KRW and our intrinsic valuation, Korea Bio-Gen Co Ltd (318000.KQ) is undervalued by 50.00%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 5,264.63 - 8,151.69 | 6,362.06 | 50.0% |
| DCF (Growth 10y) | 5,731.99 - 8,678.53 | 6,855.95 | 61.7% |
| DCF (EBITDA 5y) | 5,572.00 - 8,719.61 | 7,008.59 | 65.3% |
| DCF (EBITDA 10y) | 6,050.73 - 9,309.43 | 7,501.26 | 76.9% |
| Fair Value | 7,229.55 - 7,229.55 | 7,229.55 | 70.51% |
| P/E | 2,450.52 - 4,056.81 | 3,432.66 | -19.0% |
| EV/EBITDA | 3,149.65 - 5,346.90 | 3,991.59 | -5.9% |
| EPV | 2,897.20 - 3,689.32 | 3,293.26 | -22.3% |
| DDM - Stable | 2,943.17 - 6,176.17 | 4,559.67 | 7.5% |
| DDM - Multi | 5,066.25 - 8,231.25 | 6,268.75 | 47.8% |
| Market Cap (mil) | 37,057.60 |
| Beta | 0.37 |
| Outstanding shares (mil) | 8.74 |
| Enterprise Value (mil) | 35,553.14 |
| Market risk premium | 5.82% |
| Cost of Equity | 6.55% |
| Cost of Debt | 4.25% |
| WACC | 6.53% |